Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10 mg".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10 mg".